deltatrials
Completed OBSERVATIONAL NCT03072576

Accuracy and Feasibility of Xpert Ultra

A Multicentre Study of the Diagnostic Accuracy and Feasibility of the Xpert Ultra for Detection of TB and Rifampin Resistance in Adults Suspected of Having Pulmonary TB

Sponsor: Foundation for Innovative New Diagnostics, Switzerland

Conditions Tuberculosis, Pulmonary
Interventions Xpert MTB/RIF Ultra
Updated 7 times since 2017 Last updated: Feb 6, 2018 Started: Mar 31, 2016 Primary completion: Mar 31, 2017 Completion: Oct 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Tuberculosis, Pulmonary and is currently completed. Foundation for Innovative New Diagnostics, Switzerland leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Mar 2017 – ~Mar 2018 · 12 months · monthly snapshotRecruiting~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 2 earlier versions

  1. Mar 2018 — Apr 2018 [monthly]

    Completed NA

    Status: Recruiting → Completed

  2. Mar 2017 — Mar 2018 [monthly]

    Recruiting NA

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Foundation for Innovative New Diagnostics, Switzerland
Data source: Foundation for Innovative New Diagnostics, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations